Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Alonso

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Vitamins and Hormones|March 7, 2020
Development and therapeutic potential of vasopressin synthetic analog [V<sup>4</sup>Q<sup>5</sup>]dDAVP as a novel anticancer agentJuan Garona, Marina Pifano, Giselle Ripoll, et al.
Frontiers in Oncology|September 14, 2012
AZT as a telomerase inhibitorDaniel E Gomez, Romina G Armando, Daniel F Alonso
Oncology Reports|September 14, 2006
Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancerHernán G Farina, Monica Pomies, Daniel F Alonso, et al.
Expert Opinion on Biological Therapy|February 24, 2016
Racotumomab for treating lung cancer and pediatric refractory malignanciesMariano R Gabri, Walter Cacciavillano, Guillermo L Chantada, et al.
Bulletin Du Cancer|March 7, 2006
Desmopressin and other synthetic vasopressin analogues in cancer treatmentDaniel E Gomez, Giselle V Ripoll, Santiago Girón, et al.
Acta Veterinaria Hungarica|March 1, 2011
Effect of atorvastatin in a case of feline multicentric lymphoma - Case reportGuillermo A Hermo, Hernán G Farina, Daniel F Alonso, et al.
International Journal of Molecular Medicine|December 8, 2004
Role of beta2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix componentsPablo Lorenzano Menna, Leticia Y Peche, Daniel F Alonso, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2009
Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell linesMariano R Gabri, Laura L Otero, Daniel E Gomez, et al.
Clinical & Experimental Metastasis|October 31, 2002
Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cellsHernán G Farina, Débora R Bublik, Daniel F Alonso, et al.
Journal of Cancer Research and Clinical Oncology|December 11, 2002
Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma modelMariano R Gabri, Giselle V Ripoll, Daniel F Alonso, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Vitamins and Hormones|March 7, 2020
Development and therapeutic potential of vasopressin synthetic analog [V<sup>4</sup>Q<sup>5</sup>]dDAVP as a novel anticancer agentJuan Garona, Marina Pifano, Giselle Ripoll, et al.
Frontiers in Oncology|September 14, 2012
AZT as a telomerase inhibitorDaniel E Gomez, Romina G Armando, Daniel F Alonso
Oncology Reports|September 14, 2006
Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancerHernán G Farina, Monica Pomies, Daniel F Alonso, et al.
Expert Opinion on Biological Therapy|February 24, 2016
Racotumomab for treating lung cancer and pediatric refractory malignanciesMariano R Gabri, Walter Cacciavillano, Guillermo L Chantada, et al.
Bulletin Du Cancer|March 7, 2006
Desmopressin and other synthetic vasopressin analogues in cancer treatmentDaniel E Gomez, Giselle V Ripoll, Santiago Girón, et al.
Acta Veterinaria Hungarica|March 1, 2011
Effect of atorvastatin in a case of feline multicentric lymphoma - Case reportGuillermo A Hermo, Hernán G Farina, Daniel F Alonso, et al.
International Journal of Molecular Medicine|December 8, 2004
Role of beta2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix componentsPablo Lorenzano Menna, Leticia Y Peche, Daniel F Alonso, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2009
Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell linesMariano R Gabri, Laura L Otero, Daniel E Gomez, et al.
Clinical & Experimental Metastasis|October 31, 2002
Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cellsHernán G Farina, Débora R Bublik, Daniel F Alonso, et al.
Journal of Cancer Research and Clinical Oncology|December 11, 2002
Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma modelMariano R Gabri, Giselle V Ripoll, Daniel F Alonso, et al.
Pageof 10